A Study of Cabergoline for the Treatment of Cocaine Dependence - 1
Completed · Phase 2 · Has a placebo group
Conditions studied: Cocaine-Related Disorders, Substance-Related Disorders
In brief
The purpose of this study is to assess cabergoline for the Treatment of Cocaine Dependence
Key facts
- Study ID
- NCT00033111
- Run by
- National Institute on Drug Abuse (NIDA)
- People needed
- 140
- Starts
- 2001-06-01
- Expected to finish
- 2004-04-01
- Last updated by the study team
- 2017-01-12
Who can join
Age: 18 and older, up to 99. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Must have a DSM-4 criteria for cocaine dependence; be seeking treatment for cocaine dependence; have the ability to understand and provide written informed consent; females of child-bearing potential using proper method of birth control.
You may not qualify if…
- Additional criteria available during screening at the site.
Where it is running
- Torrance Clinic — Torrance, California, United States
- Medical University of South Carolina — Charleston, South Carolina, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.